Hypertension pulmonaire : définition, classification et traitements
Author:
Publisher
EDP Sciences
Subject
General Biochemistry, Genetics and Molecular Biology
Link
http://www.biologie-journal.org/10.1051/jbio/2016014/pdf
Reference62 articles.
1. Badesch D.B., Tapson V.F., McGoon M.D., Brundage B.H., Rubin L.J., Wigley F.M., Rich S., Barst R.J., Barrett P.S., Kral K.M., Jöbsis M.M., Loyd J.E., Murali S., Frost A., Girgis R., Bourge R.C., Ralph D.D., Elliott C.G., Hill N.S., Langleben D., Schilz R.J., McLaughlin V.V., Robbins I.M., Groves B.M., Shapiro S., and Medsger T.A. (2000). Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.Ann Intern Med, 132, 425-434.
2. Barst R.J., Rubin L.J., Long W.A., McGoon M.D., Rich S., Badesch D.B., Groves B.M., Tapson V.F., Bourge R.C., Brundage B.H., Koerner S.K., Langleben D., Keller C.A., Murali S., Uretsky B.F., Clayton L.M., Jöbsis M.M., Blackburn S.D., Shortino D., and Crow J.W. (1996). A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension.N Engl J Med, 334, 296-301.
3. Channick R.N., Simonneau G., Sitbon O., Robbins I.M., Frost A., Tapson V.F., Badesch D.B., Roux S., Rainisio M., Bodin F., and Rubin L.J. (2001). Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.Lancet, 358, 1119-1123.
4. Fadel E., Mercier O., Mussot S., Leroy-Ladurie F., Cerrina J., Chapelier A., Simonneau G., and Dartevelle P. (2010). Long-term outcome of double-lung and heart-lung transplantation for pulmonary hypertension: a comparative retrospective study of 219 patients.Eur J Cardio-Thorac Surg, 38, 277-284.
5. Galiè N., Manes A., and Branzi A. (2004). The endothelin system in pulmonary arterial hypertension.Cardiovasc Res, 61, 227-237.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Echocardiography in the Evaluation of the Right Heart;US Cardiology Review;2022-04-04
2. Pretreatment with the active fraction of Rhodiola tangutica (Maxim.) S.H. Fu rescues hypoxia-induced potassium channel inhibition in rat pulmonary artery smooth muscle cells;Journal of Ethnopharmacology;2022-01
3. Role of Selexipag in Chronic Obstructive Pulmonary Disease (COPD) Patients With Out-of-Proportion Pulmonary Hypertension;Cureus;2021-07-20
4. Cardiac Magnetic Resonance–Derived Indexed Volumes and Volume Ratios of the Cardiac Chambers Discriminating Group 2 Pulmonary Hypertension From Other World Health Organization Groups;Journal of Computer Assisted Tomography;2020-09-24
5. Bendopnea and Its Clinical Importance in Outpatient Patients with Pulmonary Arterial Hypertension;ACTA CARDIOL SIN;2018
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3